Brief: Adicet Bio Announces FDA Clearance Of Ind Application For Adi-212
27/08/2026 21:32
BRIEF-Adicet Bio Announces FDA Clearance Of Ind Application For Adi-212 Aug 27 (Reuters) - ADICET Bio, Inc. ACET.O:
ADICET BIO ANNOUNCES FDA CLEARANCE OF IND APPLICATION FOR ADI-212
ADICET BIO, - TO BEGIN PHASE 1 ENROLLMENT FOR ADI-212 IN MCRPC IN Q4 2026
Source text: ID:nBw5JmdMNa
Further company coverage: ACET.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on ADICET Bio
See all newsNASDAQ RESUMED AT 09:35 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:30 AM
Brief: Adicet Bio Announces Positive Safety And Efficacy Data From Prula-Cel (Formerly Adi-001) Study In Patients With Systemic Lupus Erythematosus With Or Without Lupus Nephritis
Brief: Adicet Bio Announces FDA Clearance Of Ind Application For Adi-212
Adicet Bio, Inc. Reports Results For The Quarter Ended June 30: Earnings Summary